Literature DB >> 16330884

Growth hormone deficiency and memory functioning in adults visualized by functional magnetic resonance imaging.

Lucia I Arwert1, Dick J Veltman, Jan Berend Deijen, P Sytze van Dam, Henriette A Delemarre-van deWaal, Madeleine L Drent.   

Abstract

Cognitive functioning, especially memory performance, is known to be impaired in patients with childhood-onset growth hormone deficiency (CO-GHD), and growth hormone substitution has been found to counteract this memory impairment. Neuropsychological and functional magnetic resonance imagining (fMRI) data acquired during a working memory task in 13 childhood-onset GH-deficient patients were compared with 13 age, sex and education level matched healthy controls. Results demonstrated that there is no difference in the quality of the performance in the working memory task between GH-deficient patients and control subjects. However, memory speed was found to be subnormal in patients. Concerning mood, patients reported more complaints of fatigue, and less vigor. Imaging data showed that patients had increased activity in dorsolateral/ventrolateral prefrontal cortex, anterior cingulate cortex, parietal cortex, supplementary motor and motor cortex, as well as in the thalamus and precuneus area. Increasing task load was also associated with an increase in brain activity in similar areas in patients compared to control subjects. In conclusion, this fMRI study shows that GH-deficient patients have a subnormal memory speed, but no impaired quality of memory performance, which may be due to compensatory recruitment of dorsal prefrontal brain regions. These findings indicate that the GH-IGF-1 axis contributes to prefrontal functioning in patients with CO-GHD. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330884     DOI: 10.1159/000090123

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  8 in total

Review 1.  What are critical outcome measures for patients receiving pituitary replacement following brain injury?

Authors:  Sorin G Beca; Walter M High; Brent E Masel; Kurt A Mossberg; Randall J Urban
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 2.  Growth hormone and cognitive function.

Authors:  Fred Nyberg; Mathias Hallberg
Journal:  Nat Rev Endocrinol       Date:  2013-04-30       Impact factor: 43.330

3.  Neuropsychological recovery and quality-of-life in children and adolescents with growth hormone deficiency following TBI: a preliminary study.

Authors:  Julia B Wamstad; Kenneth W Norwood; Alan D Rogol; Matthew J Gurka; Mark D Deboer; James A Blackman; Marcia L Buck; Michelle N Kuperminc; Jodi G Darring; Peter D Patrick
Journal:  Brain Inj       Date:  2013       Impact factor: 2.311

4.  Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Authors:  Eric R Braverman; Thomas J H Chen; Thomas J Prihoda; William Sonntag; Brian Meshkin; B William Downs; Julie F Mengucci; Seth H Blum; Alison Notaro; Vanessa Arcuri; Michael Varshavskiy; Kenneth Blum
Journal:  Age (Dordr)       Date:  2007-05-12

5.  The GH/IGF-I Axis and Cognitive Changes across a 4-Year Period in Healthy Adults.

Authors:  Jan Berend Deijen; Lucia I Arwert; Madeleine L Drent
Journal:  ISRN Endocrinol       Date:  2011-04-03

Review 6.  Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth?

Authors:  Jesús Devesa; Cristina Almengló; Pablo Devesa
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2016-10-12

7.  Effects of growth hormone-releasing hormone receptor antagonist MIA-602 in mice with emotional disorders: a potential treatment for PTSD.

Authors:  Lucia Recinella; Annalisa Chiavaroli; Giustino Orlando; Claudio Ferrante; Serena Veschi; Alessandro Cama; Guya Diletta Marconi; Francesca Diomede; Iacopo Gesmundo; Riccarda Granata; Renzhi Cai; Wei Sha; Andrew V Schally; Luigi Brunetti; Sheila Leone
Journal:  Mol Psychiatry       Date:  2021-07-30       Impact factor: 15.992

8.  Exercise and obesity in fibromyalgia: beneficial roles of IGF-1 and resistin?

Authors:  Jan L Bjersing; Malin Erlandsson; Maria I Bokarewa; Kaisa Mannerkorpi
Journal:  Arthritis Res Ther       Date:  2013-02-27       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.